Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT06826196
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 24, 2025
Completion: Jun 30, 2026